News and Events
- Monday, November 18, 2013
Genelux Corporation’s GL-ONC1 selected by Elsevier among its “Top 10 Oncology Projects to Watch”… more
- Thursday, June 14, 2012
Genelux Corporation Announces First Patient Dosed in Phase I Combination Clinical Trial of
GL-ONC1… more
GL-ONC1… more
- Thursday, May 31, 2012
Genelux Corporation Announces Treatment of First Patient in Phase I/II Clinical Trial of GL-ONC1 in Advanced Peritoneal Cavity Cancers… more
- Wednesday, May 30, 2012
Genelux Corporation Announces Phase I Data Presentation at 2012 ASCO Annual Meeting of GL-ONC1, its Oncolytic Virus Lead Product Candidate… more
- Thursday, August 4, 2011
Genelux Corporation Appoints Catherine J. Mackey, PhD to Board of Directors… more
- Monday, June 6, 2011
Preliminary results of Phase I Clinical Trial involving Intravenous Administration of GL-ONC1 to Patients with Advanced Solid Tumor Cancers presented at ASCO… more
- Monday, January 24, 2011
Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive…more
- Sunday, November 14, 2010
Genelux Awarded Therapeutic Discovery Project Grant…more